In line with that, Wang and colleagues [155] identified MEF2C point pathogenic mutations in the absence of Mecp2 gene mutations in patients with RTT suggesting that the MEF2C gene itself can be considered a candidate for a risk gene in RTT. The gene discussed is MECP2; the disease is Rett syndrome.